Interferon response factor 3 is essential for house dust mite–induced airway allergy - 07/08/11
Abstract |
Background |
Pattern-recognition receptors (PRRs) are critically involved in the pathophysiology of airway allergy, yet most of the signaling pathways downstream of PRRs implicated in allergic airway sensitization remain unknown.
Objective |
We sought to study the effects of genetic depletion of interferon response factor (IRF) 3 and IRF7, important transcription factors downstream of various PRRs, in a murine model of house dust mite (HDM)–induced allergic asthma.
Methods |
We compared HDM-induced allergic immune responses in IRF3-deficient (IRF3−/−), IRF7−/−, and wild-type mice.
Results |
Parameters of airway allergy caused by HDM exposure were strongly attenuated in IRF3−/−, but not IRF7−/−, mice compared with those in wild-type mice. Indeed, in HDM-exposed IRF3−/− mice HDM-specific TH2 cell responses did not develop. This correlated with impaired maturation and migration of IRF3−/− lung dendritic cells (DCs) on HDM treatment. Furthermore, adoptive transfer of HDM-loaded DCs indicated that IRF3−/− DCs had an intrinsic defect rendering them unable to migrate and to prime HDM-specific TH2 responses. Intriguingly, we also show that DC function and allergic airway sensitization in response to HDM were independent of signaling by type I interferons, the main target genes of IRF3.
Conclusion |
Through its role in DC function, IRF3, mainly known as a central activator of antiviral immunity, is essential for the development of TH2-type responses to airway allergens.
El texto completo de este artículo está disponible en PDF.Key words : Airway allergy, interferon response factor 3, interferon response factor 7, dendritic cell, type I interferon
Abbreviations used : BLN, BMDC, CFSE, DC, HDM, IFNAR2, IRF, MyD88, OVA, PRR, TLR, TRIF, WT
Esquema
The Laboratory of Cellular and Molecular Physiology is supported by grants of the Fonds National de la Recherche Scientifique (FNRS; Belgium; Mandat d’Impulsion Scientifique), by the Fonds de la Recherche Scientifique Médicale (FRSM; Belgium), and by the Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE) initiated by the Belgian State (Belgian Science Policy). T.M., D.B., and C.M. are research fellows, C.J.D. is a postdoctoral researcher, and S.G. is research associate of the National Fund for Scientific Research Belgium (FRS-FNRS, Belgium). |
|
Disclosure of potential conflict of interest: D. Cataldo has received grants from Fonds National de la Recherche Scientifique (FNRS) and Walloon Regional Government (Belgium). |
Vol 126 - N° 4
P. 836 - octobre 2010 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?